六块爱理不理 8块高攀不起查看全文
格隆汇11月15日丨Aytu BioPharma(AYTU.US)盘前涨18.76%,报0.23美元。公司2023年Q1财报实现营收2765.5万美元,前值为2189.7万美元,预期值为2430万美元,超出市场预期13.81%;每股收益为-0.06美元,前值为-0.33美元,预期值为-0.18美元,超出市场预期66.67%。 网页链接
$Aytu BioPharma(AYTU)$ S-1/A [Amend] General form for registration of securities under the Securities Act of 1933 Accession Number: 0001104659-23-068133 Act: 33 Size: 1 MB 网页链接
$Aytu BioPharma(AYTU)$ SC 13D General statement of acquisition of beneficial ownership Accession Number: 0001104659-23-065376 Act: 34 Size: 81 KB 网页链接
$Aytu BioPharma(AYTU)$ 8-K Current report, items 5.07 and 9.01 Accession Number: 0001558370-23-010277 Act: 34 Size: 168 KB 网页链接
$Aytu BioPharma(AYTU)$ CT ORDER Confidential treatment order Accession Number: 9999999997-23-002822 Act: 34 Size: 124 KB 网页链接
$Aytu BioPharma(AYTU)$ 8-K Current report, items 2.02 and 9.01 Accession Number: 0001558370-23-009383 Act: 34 Size: 494 KB 网页链接
$Aytu BioPharma(AYTU)$ 10-Q Quarterly report [Sections 13 or 15(d)] Accession Number: 0001558370-23-009367 Act: 34 Size: 13 MB 网页链接
$Aytu BioPharma(AYTU)$ S-1 General form for registration of securities under the Securities Act of 1933 Accession Number: 0001104659-23-054549 Act: 33 Size: 727 KB 网页链接
$Aytu BioPharma(AYTU)$ 8-K Current report, items 1.01, 7.01, and 9.01 Accession Number: 0001558370-23-007404 Act: 34 Size: 188 KB 网页链接
$Aytu BioPharma(AYTU)$ 8-K Current report, items 7.01, 8.01, and 9.01 Accession Number: 0001558370-23-006964 Act: 34 Size: 183 KB 网页链接
$Aytu BioPharma(AYTU)$ 8-K Current report, item 8.01 Accession Number: 0001558370-23-006188 Act: 34 Size: 243 KB 网页链接